Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001415889-25-001117
Filing Date
2025-01-08
Accepted
2025-01-08 16:07:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4974
  Complete submission text file 0001415889-25-001117.txt   6968
Mailing Address 399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116
Business Address 399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116 6174259200
MPM BioImpact LLC (Filed by) CIK: 0001687078 (see all company filings)

EIN.: 364818254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Subject) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93112 | Film No.: 25518599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)